Minimal Early Mortality in CABG - Simply a Question of Surgical Quality?

Abstract

Background: The increasing number of risk scores and models for the evaluation of the early risk after cardiac surgery reflects the interest in ‘calculating’ the risk of adverse events. Different time intervals, but also different ‘types’ of death are generally accepted in the evaluation of early mortality. The aim of this study was to focus on the differences in the calculation of early mortality and to focus on their potentially misleading impact on risk stratification. Methods: We investigated 7436 patients who underwent coronary artery bypass grafting from June 30, 1988 through June 30, 2001. A follow-up was performed 180 days after operation (98.7 % complete). Results: According to the definition of 30-day mortality to represent the total time interval between an intervention and the 30^th postoperative day, the 30-day mortality was 5.92 % (n = 440 patients). Hospital mortality reflects the number of deaths from the day of intervention through the patient's individual discharge, independent of any fixed time interval. Hospital mortality was 5.86 % (n = 436 patients) in our patient group. 30-day hospital mortality requires the investigation of hospital mortality until the 30^th postoperative day; in-hospital and general mortality after the 30^th postoperative day remained excluded from the analysis; 30-day hospital mortality was 5.19 % (n = 386 patients). Assuming a maximum hospital stay of 5 days, hospital mortality would decrease to 2.64 % (n = 196 patients). Conclusions: 30-day mortality, hospital mortality and 30-day hospital mortality are used to determine early outcome. The present data indicate the vulnerability of non-standardized time intervals to discharge policy. However, both hospital mortality and 30-day hospital mortality are predominantly used in current risk scores and models. In view of the comparability and meaning of data, the methodology for the evaluation of early risk should be reconsidered.

Key words

Mortality - Heart surgery - Test scoring systems

References

• 1 Vahl C F, Herold U, Thomas G, Tochtermann U, Schweiger P, Carl I, Hagl S. Das „Heidelberger Modell”. In: Krian A, Scheld HH (eds.) Dokumentationsverfahren in der Herzchirurgie. Darmstadt: Steinkopff-Verlag 1995: 1-6
• 2 Vahl C F, Meinzer P, Thomas G, Osswald B R, Hagl S. Qualitätssicherung in der Herzchirurgie: acht Jahre Erfahrung mit einem ‘Feedback-control’ System in Heidelberg.  Herz. 1996;  21 371-382
• 3 Caplan A L. Time to get down and dirty in defining misconduct.  J Lab Clin Med. 1997;  129 172-173
• 4 Parsonnet V, Dean D, Bernstein A D. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease.  Circulation. 1989;  79 13-112
• 5 Osswald B R, Tochtermann U, Thomas G, Vahl C F, Hagl S. The influence of follow-up response rate on risk factor analysis.  Thorac Cardiovasc Surg. 1999;  47 33-37
• 6 Sergeant P, Blackstone E, Meyns B. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG.  Eur J Cardiothorac Surg. 1997;  12 1-9
• 7 Osswald B R, Tochtermann U, Thomas G, Schweiger P, Vahl C F, Hagl S. Anwendung der zeitadjustierten parametrischen Hazardfunktion - Methodik und Ziele. A. Krian, H.H. Scheld (Hrsg.) Dokumentationsverfahren in der Herzchirurgie IV. Steinkopff Verlag 1999: 75-86
• 8 Osswald B R, Blackstone E H, Tochtermann U, Schweiger P, Thomas G, Vahl C F, Hagl S. The meaning of early mortality after CABG.  Eur J Cardiothor Surg. 1999;  15 401-407
• 9 Edwards F H, Grover F L, Shroyer A LW, Schwartz M, Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: Current risk assessment.  Ann Thorac Surg. 1997;  63 903-908
• 10 Ghali W A, Ash A S, Hall R E, Moskowitz M A. Statewide quality improvement initiatives and mortality after cardiac surgery.  JAMA. 1997;  277 379-382
• 11 Roques F, Nashef S AM, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones M T, Pinna Pintor P, Salamon R, Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.  Eur J Cardiothorac Surg. 1999;  15 816-823
• 12 Higgins T L, Estafanous F G, Loop F D, Beck G J, Blum J M, Paranandi L. Stratification of Morbidity and Mortality Outcome by Preoperative Risk Factors in Coronary Artery Bypass Patients.  JAMA. 1992;  267 2344-2348
• 13 Osswald B R, Tochtermann U, Schweiger P, Thomas G, Gohring D, Vahl C F, Hagl S. Target, application and interpretation of scores and alternative methods for risk assessment in cardiac surgery.  Thorac Cardiovasc Surg. 2000;  48 72-78
• 14 Silber J H, Rosenbaum P R, Schwartz J S, Ross R N, Williams S V. Evaluation of the complication rates as a measure of quality of care in coronary artery bypass graft surgery.  JAMA. 1995;  274 317-323
• 15 Silber J H, Williams S V, Krakauer H, Schwartz J S. Hospital and patient characteristics associated with death after surgery. A study of adverse occurrence and failure to rescue.  Med Care. 1992;  30 615-629
• 16 Lauer M, Blackstone E H, Young J B, Topol E J. Causes of death in clinical research.  J Am Coll Cardiol. 1999;  34 618-620
• 17 Gottlieb E. Dead is dead - artificial definitions are no substitute.  Lancet. 1997;  349 662-663
• 18 Julian D G, Camm A J. Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.  Lancet. 1997;  349 667-674, - errata 349: 1180, 349: 1776